XTL Biopharmaceuticals Ltd.
XTLB
Last
$1.98
Day
+0.0%
1y
+74.6%
5y
-43.3%
52w
-59.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
2.24
EMA 50
2.43
EMA 200
2.18
20d high
-22.3%
5y high
-70.3%
5y range
24th
Positions held
Your positionsXTLB isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-16
Hold
avoid
Signal
Strong Sell
Target
$2.31
Stop
$1.72
Stop distance
13.1%
Target vs last
+16.7%
Fundamentals
| Market cap | $4.89M | Enterprise value | $4.81M | Trailing P/E | — | Forward P/E | — |
| PEG | 2.27 | Price / book | — | Beta | 0.43 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -29.3% | ROA | -21.0% | Debt / equity | — |
| Current ratio | 0.40 | Free cash flow | -$2.12M | Analyst recommendation | none | Mean target | — |
| 52w high | $6.48 | 52w low | $1.97 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$7.0M | -$1.0M | -$1.8M | -$1.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Operating income | -$1.4M | -$0.8M | -$0.8M | -$0.9M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsXTLB · daily-16.3% over 13 sessions
Close EMA21 EMA50 EMA200